Clincosm LogoSign in Get a demo

Gastrointestinal Stromal Tumor (GIST)

Showing NaN - NaN of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastrointestinal Stromal Tumor (GIST), Digestive System Disease, Gastrointestinal Diseases Trial in Boston (IDRX-42)

Recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • +3 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 16, 2022

Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

Terminated
Has Results
  • Melanoma
  • +4 more
  • Scottsdale, Arizona
  • +11 more
Feb 18, 2020

Gastrointestinal Stromal Tumor (GIST) Trial in United States (AT13387 and Imatinib)

Completed
  • Gastrointestinal Stromal Tumor (GIST)
  • AT13387 and Imatinib
  • Tucson, Arizona
  • +7 more
Jan 13, 2020

Gastrointestinal Stromal Tumor (GIST) Trial in United States (imatinib mesylate)

Completed
Has Results
  • Gastrointestinal Stromal Tumor (GIST)
  • imatinib mesylate
  • La Jolla, California
  • +20 more
Mar 9, 2018

Gastrointestinal Stromal Tumor (GIST) Trial in Stanford, Boston (Pazopanib)

Terminated
Has Results
  • Gastrointestinal Stromal Tumor (GIST)
  • Stanford, California
  • +1 more
Feb 22, 2017

Gastrointestinal Stromal Tumor (GIST) Trial in Worldwide (Olaratumab)

Terminated
Has Results
  • Gastrointestinal Stromal Tumor (GIST)
  • Olaratumab
  • Chicago, Illinois
  • +12 more
Jan 27, 2017

Gastrointestinal Stromal Tumor (GIST) Trial in Worldwide (Nilotinib (AMN107), imatinib (STI571))

Completed
Has Results
  • Gastrointestinal Stromal Tumor (GIST)
  • Nilotinib (AMN107)
  • imatinib (STI571)
  • Birmingham, Alabama
  • +164 more
May 10, 2016